We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$801B
AUM Growth
-$29.1B
Cap. Flow
+$16.3B
Cap. Flow %
2.03%
Top 10 Hldgs %
24.5%
Holding
5,100
New
137
Increased
3,082
Reduced
1,102
Closed
125

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.3B
2
MSFT icon
Microsoft
MSFT
+$1.3B
3
AMD icon
Advanced Micro Devices
AMD
+$925M
4
SPGI icon
S&P Global
SPGI
+$894M
5
TSLA icon
Tesla
TSLA
+$716M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Financials 13.32%
3 Healthcare 13.3%
4 Consumer Discretionary 11.44%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGAC
4051
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$406K ﹤0.01%
41,208
NINE
4052
DELISTED
Nine Energy Service
NINE
$404K ﹤0.01%
108,152
-12,630
-10% -$23.8K
TUSK icon
4053
Mammoth Energy Services
TUSK
$130M
$404K ﹤0.01%
189,939
-90,465
-32% -$164K
STSA
4054
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$404K ﹤0.01%
106,370
+884
+0.8% +$3.98K
IMTX icon
4055
Immatics
IMTX
$1.23B
$403K ﹤0.01%
50,502
-404
-0.8% -$3.68K
TCON
4056
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$402K ﹤0.01%
7,653
+457
+6% +$23K
BWMX icon
4057
Betterware México
BWMX
$639M
$401K ﹤0.01%
23,570
LIQT icon
4058
LiqTech
LIQT
$21.3M
$401K ﹤0.01%
20,509
+212
+1% +$9.2K
GPUS
4059
Hyperscale Data Inc
GPUS
$56.1M
$400K ﹤0.01%
3
+1
+50% +$142K
CDTX
4060
DELISTED
Cidara Therapeutics
CDTX
$396K ﹤0.01%
23,804
+4,723
+25% +$80.1K
AIM
4061
AIM ImmunoTech
AIM
$6.96M
$395K ﹤0.01%
3,733
PMCB icon
4062
PharmaCyte Biotech
PMCB
$6.18M
$394K ﹤0.01%
171,523
+87,948
+105% +$195K
RTLR
4063
DELISTED
Rattler Midstream LP Common Units
RTLR
$394K ﹤0.01%
28,222
PNRG icon
4064
PrimeEnergy Resources
PNRG
$300M
$393K ﹤0.01%
5,763
+44
+0.8% +$3.28K
SCPH
4065
DELISTED
scPharmaceuticals
SCPH
$393K ﹤0.01%
69,252
-1,957
-3% -$9.61K
ASAP
4066
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$393K ﹤0.01%
53,225
-87
-0.2% -$900
IDN icon
4067
Intellicheck
IDN
$77.6M
$392K ﹤0.01%
153,944
-1
-0% -$4
AGFS
4068
DELISTED
AgroFresh Solutions Inc
AGFS
$391K ﹤0.01%
206,113
-10
-0% -$20
BLU
4069
DELISTED
BELLUS Health Inc.
BLU
$390K ﹤0.01%
56,818
CHRA
4070
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$390K ﹤0.01%
7,817
+509
+7% +$26.1K
ROI
4071
DELISTED
RiskOn International, Inc. Common Stock
ROI
$389K ﹤0.01%
5,622
+3,761
+202% +$280K
CSBR icon
4072
Champions Oncology
CSBR
$80M
$387K ﹤0.01%
47,638
GIFI
4073
DELISTED
Gulf Island Fabrication
GIFI
$384K ﹤0.01%
98,199
HMNF
4074
DELISTED
HMN Financial Inc
HMNF
$384K ﹤0.01%
15,522
CADL icon
4075
Candel Therapeutics
CADL
$749M
$382K ﹤0.01%
75,217
+16,932
+29% +$84.1K

Similar funds

Geode Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
  • Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
  • Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
  • Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
  • Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
  • Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
  • Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.